Hartmann · Journal of psychiatric research · narrative review of controlled trials · n=40 studies

Effects of L-tryptophan on sleepiness and on sleep.

Cited 107 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Narrative review of 40 controlled studies without systematic review or meta-analytic methodology

PubMed 6764927 · doi:10.1016/0022-3956(82)90012-7 · record verified 2026-08-31

What was done

This review summarized 40 controlled human studies published over a 20-year period assessing the effects of L-tryptophan on sleepiness and sleep parameters across normal subjects, individuals with mild or severe insomnia, and patients with medical or psychiatric illness.

What was found

The abstract reports that L-tryptophan at doses of 1 g or more increased subjective sleepiness ratings and decreased sleep latency. Less consistent evidence suggested possible decreases in total wakefulness and increases in total sleep time. Benefits were clearest in participants with mild insomnia or normal subjects with longer baseline sleep latency. Mixed or negative findings were noted in completely normal subjects, severe insomniacs, and patients with serious medical or psychiatric conditions. No specific numerical values or statistical metrics were provided in the abstract.

Why it matters

The review characterizes the target population for L-tryptophan, indicating it may help mild sleep-onset latency issues but lacks consistent efficacy for severe insomnia or normal baseline sleepers.

Limits

The abstract describes a narrative review without formal systematic search criteria, quality appraisal, or meta-analytic pooling. Specific participant counts, study protocols, numerical effect sizes, and adverse event data are omitted.

Cited by